Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [F]FDG PET/CT predicts survival in multiple myeloma.

Abstract

Authors

• Christos Sachpekidis
  Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany. c.sachpekidis@dkfz-heidelberg.de.
• Olof Enqvist
  Department of Electrical Engineering, Region Västra Götaland, Chalmers University of Technology, Gothenburg, Sweden.
• Johannes Ulén
  Eigenvision AB, Malmö, Sweden.
• Annette Kopp-Schneider
  Division of Biostatistics, German Cancer Research Center, Im Neuenheimer Feld 581, 69210, Heidelberg, Germany.
• Leyun Pan
  Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.
• Elias K Mai
• Marina Hajiyianni
  Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
• Maximilian Merz
  Department of Hematology and Cell Therapy, University of Leipzig, Leipzig, Germany.
• Marc S Raab
  Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
• Anna Jauch
  Institute of Human Genetics.
• Hartmut Goldschmidt
• Lars Edenbrandt
  Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
• Antonia Dimitrakopoulou-Strauss

Keywords

No keywords available for this article.

External Resources